SOUTH SAN FRANCISCO, Calif. (AP) _ Portola Pharmaceuticals Inc. (PTLA) on Tuesday reported a loss of $53.8 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 95 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.
The biopharmaceutical company posted revenue of $13.7 million in the period.
For the year, the company reported that its loss widened to $269 million, or $4.76 per share. Revenue was reported as $35.5 million.
Portola Pharmaceuticals shares have risen 55 percent since the beginning of the year. The stock has climbed 23 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTLA at https://www.zacks.com/ap/PTLA
Keywords: Portola Pharmaceuticals, Earnings Report